In a filing, Doximity Inc revealed its Director Wampler Kira Scherer unloaded Company’s shares for reported $0.11 million on May 01 ’25. In the deal valued at $56.93 per share,2,000 shares were sold. As a result of this transaction, Wampler Kira Scherer now holds 16,618 shares worth roughly $0.89 million.
Then, Bryson Anna sold 50,000 shares, generating $3,000,000 in total proceeds. Upon selling the shares at $60.00, the Chief Financial Officer now owns 357,165 shares.
Before that, Bryson Anna sold 45,000 shares. Doximity Inc shares valued at $2,575,235 were divested by the Chief Financial Officer at a price of $57.23 per share. As a result of the transaction, Bryson Anna now holds 357,165 shares, worth roughly $19.2 million.
Piper Sandler upgraded its Doximity Inc [DOCS] rating to an Overweight from a a Neutral in a research note published on February 07, 2025; the price target was increased to $78 from $31. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who increased its forecast for the stock in early February from “a Market perform” to “an Outperform”. Stephens began covering DOCS with “an Equal-weight” recommendation on December 20, 2024. Mizuho started covering the stock on December 04, 2024. It rated DOCS as “a Neutral”.
Price Performance Review of DOCS
On Monday, Doximity Inc [NYSE:DOCS] saw its stock jump 2.30% to $53.77. Over the last five days, the stock has lost -11.91%. Doximity Inc shares have risen nearly 0.71% since the year began. Nevertheless, the stocks have risen 125.45% over the past one year.
How much short interest is there in Doximity Inc?
A steep rise in short interest was recorded in Doximity Inc stocks on 2025-04-30, growing by 1.75 million shares to a total of 9.03 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-31 was 7.27 million shares. There was a rise of 19.43%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on November 15, 2024 when Goldman began covering the stock and recommended ‘”a Neutral”‘ rating along with a $58 price target.
